Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
1.358
+0.098 (7.79%)
Mar 12, 2026, 3:17 PM EDT - Market open
Allarity Therapeutics Market Cap
Allarity Therapeutics has a market cap or net worth of $21.84 million as of March 12, 2026. Its market cap has increased by 598.77% in one year.
Market Cap
21.84M
Enterprise Value
4.76M
1-Year Change
598.77%
Ranking
Category
Stock Price
$1.36
Market Cap Chart
Since December 21, 2021, Allarity Therapeutics's market cap has decreased from $79.38M to $21.84M, a decrease of -72.48%. That is a compound annual growth rate of -26.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 20.26M | 18.73% |
| Dec 31, 2025 | 17.07M | 229.00% |
| Dec 31, 2024 | 5.19M | 106.50% |
| Dec 29, 2023 | 2.51M | -40.12% |
| Dec 30, 2022 | 4.20M | -94.65% |
| Dec 31, 2021 | 78.43M | -1.20% |
| Dec 21, 2021 | 79.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Daré Bioscience | 21.29M |
| NanoViricides | 20.99M |
| Citius Pharmaceuticals | 20.83M |
| Polyrizon | 20.66M |
| Genenta Science | 20.20M |
| VYNE Therapeutics | 20.05M |
| Intensity Therapeutics | 19.56M |
| IO Biotech | 19.12M |